Who are we?
The company, founded in 2018, has developed the world’s first ECG device that can measure heart signals anywhere and anytime. The data then synchronizes wirelessly to the hospital.
Behind MedBeat is a team with a broad background from healthcare and the technology industry who understand the importance of making a product that is easy to use.
One of the challenges in medicine today is cardiac arrhythmias. The most common is atrial fibrillation that exists in around 2% of the world’s population. The biggest problem with atrial fibrillation is not the irregular heartbeat, but the blood clots that occur. Studies have shown that about 30% of all strokes are associated with atrial fibrillation.
MedBeat’s device can detect several different arrhythmias, including atrial fibrillation. It can be used anywhere – e.g. at home, at work or at training. The device is used both to diagnose known symptoms and to prevent sudden cardiac death and stroke.
Working at MedBeat
We are a medtech startup developing a modern solution to diagnose arrhythmias. We can offer you flexible working hours, skill development, new tech gear and of course paid holiday.
Please visit our LinkedIn page to discover more about us.
You are welcome to submit a spontaneous application!
Please use the form here on the website.